MeiraGTx Holdings plc — Quarterly Financial Statistics (NASDAQ:MGTX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 25 M23.28 M36.8 M44 M12.2 M 116.28 M Cash from investing activities -1.31 M-1.22 M1.71 M761 K547 K 1.8 M Cash from financing activities 49.96 M4.24 M1.71 M5.45 M-219 K 11.19 M Free cash flow 24.27 M22.06 M35.09 M42.77 M11.59 M 111.51 M

Notizie

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates

Il titolo MeiraGTx sale dopo accordo di licenza esclusiva con ZipBio

MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy

MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy

MeiraGTx Holdings stipula accordo per riacquistare 2,3 milioni di azioni da Perceptive

Il titolo Eli Lilly raggiunge il massimo storico di 1057,42 USD

Truist Securities raises Eli Lilly stock price target to $1,182 on obesity drug outlook

JPMorgan raises Eli Lilly stock price target to $1,150 on obesity drug outlook

Obiettivo di prezzo di MeiraGTx alzato a $16 da $12 da RBC Capital

MeiraGTx stock price target raised to $16 from $12 at RBC Capital

Gli EPS di MeiraGTx hanno mancato le aspettative per 0,13$, il fatturato appena sotto le previsioni

MeiraGTx earnings missed by $0.13, revenue fell short of estimates